Fractyl Health, Inc. GUTS
0.49
0.02
4.26%
as of 25 Sep
- Market cap
- $76.4M
- P/E
- 0.0×
Follow GUTS
Insider Buys
alert about insiders buying in the last 12 month
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| 1,063.04% | (778.33%) | (744.17%) | (511.03%) |
+8 more TTM periods Free account |
|
| (146.75%) | (118.41%) | (122.85%) | (99.89%) | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
(295.82%) | (205.18%) | (196.71%) | (189.09%) | |
Average Days of Receivables |
— | — | — | — | |
Free Cash Flow per Share |
(0.52) | (0.55) | (1.20) | (1.34) | |
Free Cash Flow |
(82.43) | (87.73) | (90.88) | (86.81) | |
Capital Expenditures |
— | — | (0.56) | (0.79) | |
| Other line items | |||||
Cash ROIC |
(108.57%) | (76.50%) | (74.29%) | (81.74%) | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.78 | 0.81 | 0.64 | 0.71 | |
Depreciation/Fixed assets |
0.61 | 0.53 | 0.47 | 0.40 | |
Capex/Depreciation |
0.00 | 0.00 | (0.49) | (0.73) | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.52) | (0.55) | (1.19) | (1.33) | |
Capex per Share |
0.00 | 0.00 | (0.01) | (0.01) | |
Capex to Sales |
— | — | 0.00 | 0.00 | |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates